Showing results (521-530 of 578) with videos related to

Sort By:
Pageof 58
British Journal of Cancer|September 16, 2021
Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK auditAlexa Childs, Nekisa Zakeri, Yuk Ting Ma, et al.
BMJ Open Sport & Exercise Medicine|October 7, 2024
SoccHealth: a health status examination of former professional football (soccer) players within the German National CohortKlaus Berger, Hansjoerg Baurecht, Michael Stein, et al.
Circulation Research|August 21, 2015
Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction ModelJohannes Riegler, Malte Tiburcy, Antje Ebert, et al.
The Oncologist|December 16, 2017
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine TumorsRamon Salazar, Rocio Garcia-Carbonero, Steven K Libutti, et al.
Liver Cancer|May 27, 2026
An International Phase 4 Study of Lenvatinib and Sorafenib in Real-World Patients with Unresectable Hepatocellular Carcinoma: Final AnalysisMarkus Peck-Radosavljevic, Akhmed Abdelgafur, Alessandro Granito, et al.
Resuscitation|October 21, 2025
European Resuscitation Council Guidelines 2025 Special Circumstances in ResuscitationCarsten Lott, Vlasios Karageorgos, Cristian Abelairas-Gomez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2015
Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine TumorAnna Karpathakis, Harpreet Dibra, Chistodoulos Pipinikas, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 18, 2025
Persons With Multiple Sclerosis Reveal Distinct Kynurenine Pathway Metabolite Patterns: A Multinational Cross-Sectional StudyMarie Kupjetz, Martin Langeskov-Christensen, Morten Riemenschneider, et al.
The Lancet. Gastroenterology & Hepatology|June 27, 2017
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trialTim Meyer, Richard Fox, Yuk Ting Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2020
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular CarcinomaRichard S Finn, Masafumi Ikeda, Andrew X Zhu, et al.
Pageof 58